• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Nanodiamonds Deliver Chemotherapy Drugs Directly to Brain Tumors

  Nanodiamond particles bound to chemotherapeutic agents
  Nanodiamond particles bound to chemotherapeutic agents can be used to treat a broad range of tumor models. The nanodiamond-drug hybrids are capable of markedly improving the efficacy and safety of cancer treatment.
Illustration: Courtesy of Dr. Dean Ho.

Researchers at UCLA’s Jonsson Comprehensive Cancer Center have developed an innovative drug-delivery system in which tiny particles called nanodiamonds are used to carry chemotherapy drugs directly into brain tumors. The new method was found to result in greater cancer-killing efficiency and fewer harmful side effects than existing treatments.

The research was a collaboration between Dean Ho, PhD, of the UCLA School of Dentistry, and colleagues from the Lurie Children’s Hospital of Chicago and Northwestern University’s Feinberg School of Medicine.

Glioblastoma is the most common and lethal type of brain tumor, with median survival time less than one-and-a-half years. The tumors are notoriously difficult to treat; chemotherapy drugs injected alone often are unable to penetrate the system of protective blood vessels that surround the brain, known as the blood-brain barrier, and those drugs that do cross the barrier do not stay concentrated in the tumor tissue long enough to be effective.

Doxorubicin, a common chemotherapy agent, has served as a model drug for the treatment of brain tumors when injected directly into the tumor. Dr. Ho’s team originally developed a strategy for strongly attaching doxorubicin molecules to nanodiamond surfaces, creating a combined substance called ND-DOX.

Nanodiamonds are multi-faceted carbon-based particles roughly four-to-five nanometers in diameter that can carry a broad range of drug compounds. And while tumor-cell proteins are able to eject most anticancer drugs that are injected into the cell before those drugs have time to work, they can’t get rid of the nanodiamonds. Thus, drug-nanodiamond combinations remain in the cells much longer without affecting the tissue surrounding the tumor.

The researchers found that ND-DOX levels in glioblastoma tumors were retained far longer than doxorubicin alone. In addition, ND-DOX was also found to increase apoptosis — programmed cancercell death — and to decrease cell viability in brain-cancer cell lines. The results also demonstrated for the first time that the ND-DOX delivery limited the amount of doxorubicin that was distributed outside the tumor. This reduced toxic side effects and kept more of the drug in the tumor longer, increasing the drug’s tumor-killing efficiency without affecting the surrounding tissue. Survival time increased significantly in rats treated with ND-DOX, compared with those given only unmodified doxorubicin.

“Nanomaterials are promising vehicles for treating different types of cancer,” Dr. Ho says. “We’re looking for the drugs and situations where nanotechnology actually helps chemotherapy function better, making it easier on the patient and harder on the cancer.”

“Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment,” Nanomedicine: Nanotechnology, Biology and Medicine, August 5, 2013


Previous
Recent Affiliations Expand UCLA Health’s Presence
Next
Substituting Lower-cost Drugs Could Mean Big Savings


YOU ARE VIEWING

Winter 2014

Winter 2014
E-Brochure
Printable PDF
IN THIS ISSUE
  • From Gene to Genome
  • Vacuum Device Offers an Innovative Approach to Remove Blood Clots
  • Cancer Care in America Needs an Overhaul
  • Be Happy: Your Genes May Thank You for It
  • Iron May Be at Core of Alzheimer’s Disease
  • Recent Affiliations Expand UCLA Health’s Presence
  • Nanodiamonds Deliver Chemotherapy Drugs Directly to Brain Tumors
  • Substituting Lower-cost Drugs Could Mean Big Savings
  • Researchers Assess Cost of ‘Futile’ Critical-care Treatments
  • Music Cuts through the Fog of Alzheimer’s
  • Gene Mutation Increases Risk of Schizophrenia, Learning Impairment
  • The Silver Tsunami
  • A Promise Fulfilled
  • Military Engagement
  • Connecting the Dots
  • Melody Maker
  • Awards/Honors
  • UCLA Medical Alumni Bring the Miracle of Sight to People in the Developing World
  • In His Own Words: Joseph Copeland, MD ’98
  • A Visionary Evening
  • Events
  • Chairs of Distinction
  • Gifts
  • In Memoriam
  • A Thanksgiving to Remember
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth